Thomas Berg

, Germany

Professor Dr. Thomas Berg completed his medical training at the Universities of Tübingen, Freiburg and Berlin, Germany. He specialized in internal medicine in 2001 and in Gastroenterology and Hepatology in 2007 at the University Medicine Berlin, and became a lecturer in this subject in 2002. In 2002, Professor Berg took up the position of Associate Director and Professor of Medicine at the Department of Hepatology and Gastroenterology of Charité, Campus Virchow-Clinic, University Medicine in Berlin, where he was Head of the Liver Out-Patient Clinic and the Laboratory for Molecular Hepatitis and Viral Diagnostics. Since December 2009, he has been the Head of the Section of Hepatology at the University Hospital in Leipzig, Germany. His research is focused on liver transplantation, hepatocellular carcinoma, chronic viral hepatitis, and liver failure, and he participated in numerous national and international clinical trials. He is Co-Editor of the Journal of Hepatology since 2014, and member of the American (AASLD), European (EASL), and German (GASL) Associations for the Study of the Liver, The European Society for Organ Transplantation (ESOT), The European Liver and Intestine Transplant Association (ELITA), German Transplantation Society (DTG), Working Group Internal Oncology (AiO), Working Group Gastroenterological Oncology (AGO), German Cancer Society (DKG), German Society of Gastroenterology (DGVS), and the representative of the DGVS in the foundation council of the German liver foundation. He has published more than 350 articles in peer-reviewed journals and more than 100 reviews and textbook contributions. His h-index is 66 (Scopus).


Chair - Late Breaker 13 April 2019 16:00 - 18:00
More ...


Current approaches to accelerate cure? What did we learn from recent studies? 10 April 2019 08:30 - 08:45
Viral Hepatitis 13 April 2019 14:34 - 14:42
Discussion: Is HBV cure possible and how is it defined? Where are the obstacles? 10 April 2019 09:00 - 09:30
Discussion: What are the best concepts to cure HBV? What are the technical requirements? How should we do the studies? 10 April 2019 10:30 - 11:00